神经刺激设备市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00002778
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 172
Buy Now

【研究报告】神经刺激设备市场预计将从2022年的5802.47百万美元增长,到2030年预计将达到11,825.95百万美元;预计 2022 年至 2030 年复合年增长率将达到 9.3%。
市场洞察和分析师观点:
神经刺激设备是旨在调节神经系统活动的医疗设备。它们用于治疗各种神经系统疾病和慢性疼痛。神经刺激装置有多种类型,包括脊髓刺激器、深部脑刺激器、迷走神经刺激器和周围神经刺激器。这些设备可以显着改善患有各种神经系统疾病的人的生活质量。神经系统疾病患病率的增加和脊髓损伤病例的增加是市场发展的关键因素。然而,专业人士的缺乏正在阻碍神经刺激设备市场的增长。
增长动力和挑战:
老年人口容易患神经系统疾病。影响老年人的常见神经系统疾病有神经病、帕金森病、阿尔茨海默病、肌张力障碍等。根据美国国立卫生研究院 (NIH) 的数据,世界人口的 8.5%(即约 6.17 亿人)年龄在 65 岁及以上。美国和加拿大等国家与老年人口增长相关的运动障碍和精神疾病患病率很高。根据帕金森基金会的数据,帕金森症状在平均 60 岁的人群中很常见。
加拿大心理学协会指出,强迫症 (OCD) 影响着加拿大约 2% 的人口。世界卫生组织 (WHO) 指出,癫痫是一种引起癫痫发作的神经系统疾病,影响全球约 5000 万人。根据美国神经病学学会的数据,中风是美国第三大死因,其次是阿尔茨海默病,排名第六。来自同一来源的统计数据显示,近100万美国人受到帕金森病的影响,每年至少报告6万例新病例。神经系统疾病的发病率不断上升,加上抑郁症和慢性疼痛等与生活方式相关的疾病,导致越来越多地采用先进技术产品。
根据世界卫生组织的数据,神经疾病约占全球疾病负担的 6.3%。此外,根据同一消息来源,这些疾病是全世界死亡的主要原因之一。发达国家 13.2% 的死亡由它们造成,中低收入国家 16.8% 的死亡由它们造成。高死亡率和疾病负担使得临床迫切需要整合长期解决方案。此外,人们对神经系统疾病巨大负担的认识不断增强,对神经刺激器作为治疗方法的需求也随之增加。
因此,越来越多的老年人口容易患神经系统疾病,疾病患病率不断增加,人们对神经系统疾病巨大负担的认识也不断提高疾病驱动神经刺激设备市场规模。
战略见解
报告细分和范围:
全球神经刺激设备市场根据产品、应用和最终用户进行细分。根据产品,市场分为脊髓刺激器、深部脑刺激器、骶神经刺激器和迷走神经刺激器。在应用方面,神经刺激设备市场分为疼痛管理、癫痫、尿失禁、大便失禁、帕金森病等。按最终用户划分,神经刺激设备市场分为医院、专科诊所等。神经刺激设备市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
细分分析:
根据产品,神经刺激设备市场分为脊髓刺激器、深部脑刺激器、骶神经刺激器、迷走神经刺激器等。脊髓刺激器细分市场在 2022 年占据最大的市场份额,预计 2022 年至 2030 年期间复合年增长率将更高。脊髓刺激可以治疗因各种病症而导致严重慢性疼痛的患者,包括背部手术失败/蛛网膜炎、神经性疼痛/神经病变以及复杂区域疼痛综合征/反射性交感神经营养不良。一些 SCS 设备使用低频电流来改变疼痛感,产生轻微的刺痛感,称为感觉异常。其他 SCS 设备使用高频或突发脉冲来掩盖疼痛,而不会产生刺痛感。
脊髓刺激已成为治疗各种慢性疼痛的介入性疼痛管理的基础。自 1967 年首次推出以来,已经取得了进步,催生了允许微创放置和内置电池的新技术。例如,2023 年 5 月,雅培 (Abbott) 的 SCS 设备获得美国食品和药物管理局 (FDA) 的批准,用于治疗无法接受背部手术的患者的慢性背痛(称为非手术背痛)。此外,2023 年 8 月,美敦力公司 (Medtronic plc) 的 Inceptiv 闭环可充电 SCS 获得了 CE 标志批准。它是第一款具有闭环功能的美敦力 SCS 设备,可感知每个人独特的生物信号,并根据需要随时调整刺激,以使治疗与日常生活运动保持协调一致。这些发展促进了 SCS 的采用,推动了全球神经刺激设备市场的细分市场增长。
神经刺激设备市场按应用分为疼痛管理、癫痫、尿失禁和大便失禁、帕金森病等。疼痛管理领域在 2022 年占据最大的市场份额,预计 2022 年至 2030 年期间复合年增长率将更高。
慢性疼痛影响老年人、创伤和手术患者、接受不同治疗的人以及与各种身体和精神状况。根据美国疾病控制与预防中心 (CDC) 的数据,背痛是就诊的第二大原因,大约 60% 和 80% 的人在一生中都会经历腰痛,这是导致腰痛的主要原因之一。入院或手术。
神经刺激是缓解慢性疼痛的更安全、更有效的解决方案,被广泛采用。许多生物技术公司正在推出神经刺激器来帮助阿片类药物成瘾者克服疼痛和其他戒断症状。例如,2021 年 4 月,领先的医疗设备公司 Spark Biomedical 推出了一种名为 Sparrow Therapy System 的新型神经刺激设备,以帮助阿片类药物成瘾者克服戒断症状。该设备使用低剂量的电力来刺激内啡肽的产生,这有助于减轻患者在戒断期间经历的疼痛和恐惧。此外,2021年3月,Mainstay Medical在澳大利亚推出了ReActiv8,这是一种用于治疗慢性腰痛(CLBP)的植入式神经刺激设备。该装置可能对患有与腰椎多裂肌功能障碍相关的顽固性 CLBP 的成年人有帮助。 2023 年 1 月,FDA 批准了 Abbott 的 Proclaim XR 脊髓神经刺激系统,该系统支持糖尿病周围神经病变患者控制慢性疼痛。因此,上述应用和优势对 2022-2030 年神经刺激设备市场产生积极影响。
区域分析:
根据地理位置,神经刺激设备市场分为五个关键区域:北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。对北美市场的分析主要集中在三个主要国家——美国、加拿大和墨西哥。到 2022 年,美国将占据北美神经刺激设备市场的最大份额。由于神经系统疾病的患病率不断上升、研究和治疗方面的高支出,预计在预测期内美国将占据北美神经刺激设备市场的最大份额。开发、美国食品和药物管理局 (FDA) 的产品批准以及技术进步。在美国,神经血管疾病的发病率正在显着上升,并正在成为死亡的主要原因。帕金森病 (PD) 等神经系统疾病发病率的上升、人们对神经系统疾病的认识不断提高以及对开发经颅刺激器的投资不断增加,是推动美国整体神经刺激设备市场的主要因素。据观察,深部脑刺激(DBS)设备可以有效控制与帕金森病相关的震颤。多巴胺读数低和其他遗传因素是帕金森病的主要原因。根据阿尔茨海默病协会发表的一项题为“2022年阿尔茨海默病事实和数据”的研究,2022年将有近650万65岁及以上的美国人被诊断患有阿尔茨海默病。预计到2060年,这一数字将增至1380万。帕金森病基金会预测,到 2030 年,美国帕金森病患者数量预计将增加到 120 万。技术进步和新产品推出推动神经刺激设备市场。 2020年1月,雅培神经刺激器Infinity DBS系统获得美国FDA批准用于治疗帕金森病。该系统可以对大脑的特定区域(称为内苍白球(GPi))进行有针对性的治疗,该区域与帕金森病的症状有关。因此,神经系统疾病的日益流行和技术进步推动了美国神经刺激设备市场的增长。
竞争格局和主要公司:
神经刺激设备市场的发展被描述为有机和无机增长战略。许多公司都专注于有机增长战略,例如产品发布、扩张、增强和搬迁。市场上的无机增长策略包括并购、合作和协作。这些活动为神经刺激设备市场参与者的业务和客户群扩张铺平了道路。
2023 年 8 月,Mainstay Medical Holdings plc 宣布完成其 ReActiv8 治疗顽固性慢性病的 RESTORE 随机临床研究的入组腰背疼痛。该研究旨在提供与优化医疗管理的直接比较,以检验以下假设:将 ReActiv8 恢复性神经刺激疗法添加到当前的护理范例中可显着改善背痛相关的残疾。 2023 年 4 月,Synapse Biomedical, Inc. 宣布 FDA 批准 (PMA) NeuRx 隔膜起搏系统 (NeuRx DPS) 用于依赖机械通气的脊髓损伤患者。 PMA 是 FDA 要求的最严格的器械营销申请类型。 2023 年 8 月,雅培宣布美国食品和药物管理局 (FDA) 批准了其采用 FlexBurst360 疗法的新型 Proclaim Plus 脊髓刺激 (SCS) 系统。 Abbott 的下一代专有 BurstDR 刺激 FlexBurst360 疗法可覆盖躯干和/或四肢的六个区域的疼痛。它使编程能够根据个人治疗需求的变化进行调整。 2023 年 5 月,雅培宣布美国食品和药物管理局 (FDA) 批准其脊髓刺激 (SCS) 设备,用于治疗未患过慢性背痛的患者或没有资格接受背部手术,即非手术性背痛。 2021 年 1 月,美敦力公司 (Medtronic plc) 获得美国食品和药物管理局 (FDA) 批准 Vanta,这是一种高性能、免充电植入式神经刺激器 (INS),具有设备使用寿命可以优化长达 11 年。在同等设置下,Vanta 神经刺激器的使用寿命比竞争性原电池设备长近两倍。 2022 年 1 月,美敦力公司 (Medtronic plc) 的 Intellis 可充电神经刺激器和 Vanta 免充电神经刺激器获得美国食品和药物管理局的批准,用于治疗与以下疾病相关的慢性疼痛:糖尿病周围神经病变(DPN)。公司简介
Medtronic Plc波士顿科学公司Abbott LaboratoriesNevro CorpLivaNova PlcSynapse Biomedical IncNalu Medical, IncElectroCore IncMicroTransponder IncMainstay Medical
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving and restraining factors for the neurostimulation devices market?

The factors that are driving the market is the growing prevalence of neurological diseases and increasing cases of spinal cord injury are the key driving factors behind the market development. However, lack of expert professionals is hampering the market growth.

Who are the major players in market the neurostimulation devices market?

The neurostimulation devices market majorly consists of the players such Medtronic Plc, Boston Scientific Corp; Abbott Laboratories, Nevro Corp; LivaNova Plc, Synapse Biomedical Inc, Nalu Medical, Inc, ElectroCore Inc; MicroTransponder Inc, and Mainstay Medical among others.

Which segment is dominating the neurostimulation devices market?

The neurostimulation devices market is analyzed in the product, application, and end user. The market based on product, is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during the 2022-2030. The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during the 2022-2030. The neurostimulation devices market, by end user, is bifurcated into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2022 and specialty clinics segment is anticipated to register the highest CAGR in the market during 2022-2030.

What are neurostimulation devices?

Neurostimulation devices are medical devices designed to modulate the activity of the nervous system. They are used to treat various neurological conditions and chronic pain. There are several types of neurostimulation devices, including spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, peripheral nerve stimulator. These devices have the potential to significantly improve the quality of life for individuals with various neurological conditions.

The List of Companies - Neurostimulation Devices Market

  1. Medtronic Plc
  2. Boston Scientific Corp
  3. Abbott Laboratories
  4. Nevro Corp
  5. LivaNova Plc
  6. Synapse Biomedical Inc
  7. Nalu Medical, Inc
  8. ElectroCore Inc
  9. MicroTransponder Inc
  10. Mainstay Medical

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports